Hepatitis A+B vaccin

Generic name
Hepatitis A+B vaccin
Brand name
ATC Code
J07BC20
Compare …

Hepatitis A+B vaccin

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Active immunization against hepatitis A and B infections
  • Intramuscular
    • 1 year up to 16 years

      • Ambirix or Twinrix Paediatric: 2 doses of 1 ml/dose
        1st vaccination: random moment
        2nd vaccination: 6-12 months after 1st vaccination

        General guidelines for giving a booster vaccination can be derived from experience with the monovalent hepatitis A and B vaccines. A revaccination dose can be administered with the individual vaccines

    • ≥ 16 years

      • Twinrix Adult: 3 doses of 1 ml/dose
        1st vaccination: random moment
        2nd vaccination: 1 month after 1st vaccination
        3rd vaccination: 6 months after 1st vaccination

        When rapid protection is required (e.g., < 1 month before departure to risk area) administer a dose on days 0, 7 and 21; this schedule recommends a fourth dose 12 months after the first dose.

        General guidelines for giving a booster vaccination can be derived from experience with the monovalent hepatitis A and B vaccines. A revaccination dose can be administered with the individual vaccines

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

VIRAL VACCINES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Encephalitis vaccines
J07BA02
J07BA01
Influenza vaccines
J07BB02
J07BB02
Hepatitis vaccines
J07BC02
J07BC01
Measles vaccines
J07BD52
Poliomyelitis vaccines
J07BF03
Rabies vaccines
J07BG01
Rota virus diarrhea vaccines
J07BH01
Varicella zoster vaccines
J07BK01
Yellow fever vaccines
J07BL01
Papillomavirus vaccines
J07BM03
J07BM02
Other viral vaccines
J07BX04
Covid-19 vaccines
J07BN01

References

  1. GlaxoSmithKline Biologicals s.a., SmPC Ambirix (EU/1/02/224/001) Rev 18, 8-2-2024, www.ema.europa.eu
  2. GlaxoSmithKline Biologicals s.a, SmPc Twinrix Adult (EU/1/96/020/001-9) Rev 24; 07-02-2024, www.ema.europa.eu

Changes

Therapeutic Drug Monitoring


Overdose